重大公告
Change of accountant due to internal adjustment of the accounting firm
Date of occurrence of the event: Mar 8, 2019 Name of the original accounting firm and name of the original CPA: PwC Taiwan, Yu-Kuan Lin …
Board of Directors approved the Company’s 2018 individual and consolidated financial statements
Date of occurrence of the event: Mar 8, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or subsidiaries”): Head …
Announcement of the resolution of the treasury shares and the establishment of the base date for capital reduction by board of directors
Date of the board of directors resolution: Mar 8, 2019 Reason for the capital reduction: The first-time purchase of the treasury shares are obsoleted as …
Clearance of Adagloxad Simolenin (OBI-822) for a Phase III clinical study by Ministry of Health of Ukraine
Date of occurrence of the event: Feb 20, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head …
Clarification on the collaborative publication by OBI Pharma Inc. and Academia Sinica
Date of occurrence of the event: Feb 13, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head …